Great Valley Advisor Group Inc. Takes Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Great Valley Advisor Group Inc. acquired a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,763 shares of the pharmacy operator’s stock, valued at approximately $106,000.

Several other institutional investors also recently made changes to their positions in WBA. Charles Schwab Investment Management Inc. grew its stake in Walgreens Boots Alliance by 43.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after acquiring an additional 3,329,857 shares during the last quarter. Thompson Siegel & Walmsley LLC lifted its stake in Walgreens Boots Alliance by 98.8% in the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after buying an additional 2,992,648 shares in the last quarter. Newport Trust Company LLC acquired a new stake in Walgreens Boots Alliance during the 2nd quarter valued at $31,028,000. Swedbank AB purchased a new position in Walgreens Boots Alliance during the first quarter worth $16,365,000. Finally, Philip James Wealth Mangement LLC acquired a new position in shares of Walgreens Boots Alliance in the third quarter worth $5,252,000. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Performance

NASDAQ WBA opened at $9.06 on Friday. The business’s 50-day simple moving average is $9.14 and its 200-day simple moving average is $11.36. The firm has a market capitalization of $7.83 billion, a P/E ratio of -0.91, a P/E/G ratio of 1.14 and a beta of 0.69. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $27.05. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. During the same period in the previous year, the firm earned $0.67 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 5.9% on a year-over-year basis. Equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.04%. The ex-dividend date is Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio is presently -9.99%.

Wall Street Analyst Weigh In

A number of analysts recently commented on WBA shares. JPMorgan Chase & Co. dropped their price objective on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. UBS Group boosted their price objective on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Truist Financial reduced their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research note on Monday, October 7th. Bank of America lowered their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. Finally, TD Cowen reduced their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus price target of $12.88.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.